Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 269 entries
View as:

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT00469755 Org: User:
Start: 02/28/06 End: 09/30/06 Due: 09/30/07

Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02297516 Org: User:
Start: 11/30/14 End: 03/31/17 Due: 03/31/18

Comparison of Two Botulinum Toxins Type A on Forehead Wrinkles

Phase: N/A Priority: Normal
NCT ID: NCT01014871 Org: User:
Start: 07/31/09 End: 05/31/10 Due: 05/31/11

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00472108 Org: User:
Start: 12/31/00 End: 04/30/02 Due: 04/30/03

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Phase: N/A Priority: Normal
NCT ID: NCT04501679 Org: User:
Start: 08/11/20 End: 03/31/22 Due: 03/31/23

Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles

Phase: N/A Priority: Normal
NCT ID: NCT04124692 Org: User:
Start: 11/12/19 End: 08/12/21 Due: 08/12/22

Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer

Phase: N/A Priority: Normal
NCT ID: NCT02679911 Org: User:
Start: 09/30/15 End: 06/30/16 Due: 06/30/17

Treatment of Moderate to Severe Lateral Canthal Lines

Phase: N/A Priority: Normal
NCT ID: NCT04249687 Org: User:
Start: 02/10/20 End: 02/10/21 Due: 02/10/22

Open Label Extension for 43USSA1812

Phase: N/A Priority: Normal
NCT ID: NCT04595331 Org: User:
Start: 11/12/19 End: 07/20/22 Due: 07/20/23

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable

Phase: N/A Priority: Normal
NCT ID: NCT05056779 Org: User:
Start: 01/31/23 End: 07/31/23 Due: 07/31/24

Plaque Psoriasis Study in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02186665 Org: User:
Start: 07/31/14 End: 01/31/16 Due: 01/31/17

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

Phase: N/A Priority: Normal
NCT ID: NCT04856904 Org: User:
Start: 05/28/21 End: 06/30/23 Due: 06/30/24

Restylane-L for Correction of Infraorbital Hollows

Phase: N/A Priority: Normal
NCT ID: NCT04154930 Org: User:
Start: 11/11/19 End: 04/06/22 Due: 04/06/23

Subject Preference for Scalp Psoriasis Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00438399 Org: User:
Start: 02/28/07 End: 02/29/08 Due: 02/28/09

An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01541930 Org: User:
Start: 04/30/12 End: 12/31/12 Due: 12/31/13

A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04562116 Org: User:
Start: 12/08/21 End: 06/07/23 Due: 06/07/24

Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT02396251 Org: User:
Start: 02/28/15 End: 11/14/17 Due: 11/14/18

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00437216 Org: User:
Start: 02/28/06 End: 07/31/06 Due: 07/31/07

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Phase: N/A Priority: Normal
NCT ID: NCT04269395 Org: User:
Start: 04/07/20 End: 09/01/21 Due: 09/01/22

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01753830 Org: User:
Start: 12/31/12 End: 02/28/14 Due: 02/28/15

Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel

Phase: N/A Priority: Normal
NCT ID: NCT01188538 Org: User:
Start: 03/31/10 End: 08/31/10 Due: 08/31/11

Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00862654 Org: User:
Start: 03/31/09 End: 02/28/10 Due: 02/28/11

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Phase: N/A Priority: Normal
NCT ID: NCT00469183 Org: User:
Start: 05/31/06 End: 04/30/07 Due: 04/30/08

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

Phase: N/A Priority: Normal
NCT ID: NCT00598832 Org: User:
Start: 11/30/07 End: 11/30/08 Due: 11/30/09

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Phase: N/A Priority: Normal
NCT ID: NCT01893567 Org: User:
Start: 07/31/13 End: 10/31/13 Due: 10/31/14